Icotinib Study for Patients With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors
Clinical trial NCT02934256 · COMPLETED
Trial details
- NCT number
- NCT02934256
- Sponsor
- Li Peng
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-07-01
- Primary completion
- 2018-07-01
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.